AiPing Pharmaceutical, Inc. is a fully-owned subsidiary of A&Z Pharmaceutical, Inc., a U.S. based pharmaceutical manufacturer with 30 years of global operations experience dedicated to all aspects of product development and commercialization. AiPing’s focus is on the acquisition, redevelopment and commercialization of mature, under-serviced or under-supplied generic prescription and OTC molecules requiring strong scientific, technical, and quality know-how. Our goal is to establish the AiPing label as a trusted partner of choice in the US generic pharmaceutical market.
Founded in 2014, AiPing offers our customers access to 350,000 square feet of combined facility space with the most innovative technology on the market. Our equipment and manufacturing facilities have the ability to produce high volume prescription and OTC products quickly, reliably, and most important in a challenging market, competitively.
Founded in 2014, AiPing offers our customers access to 350,000 square feet of combined facility space with the most innovative technology on the market. Our equipment and manufacturing facilities have the ability to produce high volume prescription and OTC products quickly, reliably, and most important in a challenging market, competitively.
Emma Li Xu, the Founder, CEO and Owner of AiPing Pharmaceutical, Inc, has been the recipient of a number of business awards and honors in both the United States and China.
In recognition of her exceptional business leadership and innovation, she received the 2015 Outstanding 50 Asian Americans in Business Award from Asian American Business Development Center, and was named one of the region’s Top CEOs by Long Island Business News in 2016.
In 2019, AiPing Pharmaceutical, Inc was awarded a Top Workplaces 2019 honor by Newsday. The award recognizes the company’s commitment to its staff, culture, and quality.
AiPing Pharmaceutical Inc. brings premium quality pharmaceuticals and nutritional supplements to the world.
